Amber Implants Successfully Enrolls First Human Participants for VCFix? Spinal System Clinical Trial
12 June 2024
Amber Implants, a cutting-edge medical technology company focused on innovative spinal implants, has successfully completed its first human clinical trial for the revolutionary VCFix® Spinal System. Unlike conventional treatments for vertebral compression fractures, this device operates without reliance on bone cement.
The trial evaluated the safety and effectiveness of the VCFix® Spinal System in patients with osteoporotic vertebral compression fractures. Notably, the device was predominantly used without bone cement.
Ten patients, all experiencing severe and disabling pain with Disability Ratings of 70% or higher, participated in the study. Following procedures lasting under 20 minutes, all patients experienced maximal pain reduction, with Disability Ratings decreasing to 10% or less. Moreover, they were discharged with regained ability to walk freely without disability.
Initial trial results have shown promising short-term efficacy data, showcasing the exceptional performance of the VCFix® Spinal System.
The innovation for significantly enhancing vertebrae reconstruction, The technology's user-friendliness and outstanding outcomes for patients.
Looking forward, Amber Implants is preparing for pivotal clinical trials with broader European participation. These trials will explore the device's efficacy in both stand-alone and cement-augmented configurations, as well as its compatibility with posterior fixation methods for high-energy traumatic fractures. The company aims to obtain FDA clearance for its initial indication by early 2025.
Which exceeded expectations. She emphasized the significant pain relief and improved mobility experienced by patients, highlighting the potential of VCFix® to revolutionize treatment for millions suffering from vertebral fractures annually.
Vertebral fractures affect over 8.6 million individuals worldwide each year, causing debilitating pain, reduced mobility, and increased mortality rates. Current treatment methods, involving the injection of bone cement, are associated with a high incidence of post-treatment complications.
The VCFix® Spinal System offers a disruptive alternative, designed to restore spinal integrity and stability across a spectrum of fractures, from osteoporotic to traumatic.
Source: prnewswire.com